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Summary: Sex-related differences are known to exist in the haemostatic variables of adults. In the present study,
three clotting factors were measured in cord blood of 191 newborns. A sex-related difference was found for clotting
factor VII, with higher plasma levels in female newboms (p < 0.01). Factor VIIIic also tended to be higher in
female newboms, compafed with male newborns (p = 0.07). No difference in fibrinogen concentrations was found.
The observed difference between the sexes for clotting factor VII is not easy to understand, but it is in line with
studies showing higher concentrations of factor VII in females than in males throughout adult life.
Introduction
Cardiovascular disease is about twice äs frequent in men
than in women (1). Various studies have focused on hor-
monal Status (2—4), lipid spectrum (5) and iron storage
(6), but no conclusive explanation for this difference in
incidence has been found.
Since haemostatic variables (fibrinogen, factor VlI and
to a lesser extent factor VIILc) are recognized äs import-
ant iridependent risk factors for cardiovascular disease,
they have been the subject of extensive research (7—10).
Sex-related difference in these haemostatic variables
have been shown in young adults äs well äs in the eld*
erly (11-13).
The aim of the present study was to document fibrino-
gen, clotting factor VH and factor VIII:c concentrations
in cord blood and to determine whether sex-related dif-
ferences can be demonstrated in the newbora.
Materials and Methods
Patient s
Clotting factors VII, VHI:c and fibrinogen were measured in ve-
nous cord blood from 92 male and 99 female singleton newborns
Eur. J. Clin, Chem. Clin. Biochem. / Vol. 32,1994 / No. 4
born between February and August 1992, with a gestational age of
37 weeks or more, and a birth weight between the 2.3rd and 97.7th
percentile for gestationai age (14). The haematocrit values ranged
from 0.45 to 0.51 l/l. Matemai exclusion criteria were a diastolic
blood pressure ^ 90 mmHg, an endocrine disease, a coagulation
disorder, or medication known to interfere with the haemostatic
system. Gestational age was determined by the last menstrual date
and/or ultrasound determinations. Birth weight was recorded.
Methods
Venous cord blood samples were collected in plastic, citrate-con-
täining tubes immediately after delivery and after clamping of the
umbilical cord. The tubes were filled with 9 volumes of freshly
drawn blood and l volume of trisodium citrate (0.11 mol/1). Cit-
rated plasma was prepared by direct centrifugation for 20 minutes
at 1800 g, snap frozen, then stored at -70 °C. It was thawed with
tap water at 37 °C for 5 minutes before use.
Fibrinogen was determined with the clotting assay of Clauss, a
turbidimetric method employing the CTS-fibrinogen reagent on the
Chromotime System (Behring, Marburg, Germany). To quantify
factor VII we used the chromogenic Substrate COA-set of Kabi
Vitrum Diagnostica (Mölndal, Sweden). The intra-assay coefficient
of Variation was 6.9% at the level of 54.9%. Factor VIII:c was
measured with an APTT one stage clotting assay using a deficient
plasma (Behring, Märburg, Germany).
Statistics
The Mann-Whitney U test was used to tcst the significance of dif-
ferences between groups at the p < 0.05 level.
302 van der Salm et al.: Sex dependence of cord blood clotting factors
Tub. 1 Coinpurisun of llic median and intcrcjuarlilc rangcs in 40· ~
male and fcmale neonaies. g a
& ""
Quantitics Medi n (interquartilc r nge) Signifi- g
" " "" ~ cance g. 30-
Male Fcmale p g
nconates neonates ^ 25 .
(n = 92) (n = 99)
Gcstational agc 279 281 0.64 2°
(days) (274- 285) (274- 286) 16"
Birlh weight 3525 3350 0.02
(g) (3200-3820) (3070-3750) 10-
Fibrinogen 2.2 2.2 0.68
(g/l) (1.9-2.7) (1.9-2.5) . " -
(%) (30- 56) (36- 69) ° 1
FactorVIII:c 1 07 1 42 0.07
(%) (6l- 166) (72- 192)
7 Z " b
"̂- <· t>» ' '.o ;
g 20 -
Results . = fj i
£ l
Results for the levels of fibrinogen, clotting factor VII "" 15- .
and factor VIII:c in the cord blood of 92 male and 99 j
female neonates are summarized in table 1. i i
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Gestational age did not differ between the two sexes.
Birth weight was significantly higher in male neonates 6 - -
than in female neonates. The median fibrinogen concen- l
trations were equal for male and female newboras, al-
though ihe distribuiion was aussian in males and ° o ao
skewed to the right in fernales.
Factor VII levels were significantly higher in female
than in male newborns (median values 50% and 44%, 30' c
respectively, both Gaussion distributed). ·£
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male neonates (median vahies 142% and 107%, respect- g
ively), but Ihis difference was not significant (p = 0.07). 20 "
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than in men, in the age group of 40-59 years (15). Bai-
leisen et al. also found higher fibrinogen concentrations
in females than in males up to 29 years (13), and siinilar
results were reported by Folsom et al. in subjects aged
45-64 years (12). In contrast, Berglund et al. could not
demonstrate any influence of gender on fibrinogen con- °
centration in 24-44 year-old patients (16), and Tarallo CH Male newborns
Factor VII l :c[%]
Fig. l Distribution of clotting factor concentrations in cord
blood.
a) Fibrinogen
b) Amid lytic factor VII
c) Clotting factor VIII:c
Female newborns
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et al. reported no statistical difference between the
sexes, except in subjects aged 40—50 years (17). Re-
ports on clotting factor VII are also inconclusive. Ball-
eisen et al. described no gender influence on factor VII
levels (13). Folson et al. found higher factor VII levels
in women than in men, aged 45—64 years (12), and
Kario et al. reported similar results for adults aged 60—
98 years (11). Less research has been done on sex-re-
lated differences in factor VIII:c, but Balleisen et al.
reported no difference (13). In the present study in new-
borns, no difference between the sexes could be demon-
strated in plasma fibrinogen concentrations. Factor VII
levels in cord biood were significantly higher in female
than in male neonates. Higher plasma levels of factor
VIII:c in female neonates were found, but the difference
did not reach the 0.05 level of significance (p = 0.07),
possibly because factor VIII:c levels Span a wide ränge.
The clinical relevance of the sex-related differences in
; factor VII levels in newborns might be questioned, äs
the plasma levels are lower in males than in females. It
i s unlikely that this small percentage causes a difference
in haemostasis between the two sexes. However, the pre-
sent study provides Information about the distribution of
the coagulation risk factors in the sexes at birth. It has
been stated that sex-related differences in haemostatic
! i variables are related to hormonal effects.
Heller et al. found no association between testosterone
and fibrinogen or factor VIII:c, but they found an in-
verse relationship between testosterone and factor VII
in adult males (18). Since male neonates have higher
testosterone values than female neonates (19), lower fac-
tor VII levels could be expected. The results of the pre-
sent study are in agreement with this supposition. More-
over, oestrogen replacement therapy after onset of the
menopause increases factor VII levels (12, 20). This
Supports the observation that female neonates - experi-
encing high oestrogen concentrations during the first
week of life (19) - have higher factor VII levels. Less
is known about hormonal influences on factor VIII:c. A
rise in factor VHT.c levels in the postmenopausal period
has been reported (13), but not confirmed by others (20).
Although hormonal characteristics may play a role, no
definite explanation for the differences found can be
given. It is striking, however, that plasma levels of factor
VII, an important cardiovascular risk factor, appear to
be higher in females than in males from birth to adult
life, whereas cardiovascular disease is more frequent in
men.
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